Compass Pharma Services has completed a capital investment project to upgrade its production capabilities to include ISO Class 8 (ISO 14644) specifications in order to provide packaging services for certain high-potency pharmaceutical products. “These capital improvements now allow us to provide cGMP contract packaging services for select potent pharmaceutical compounds such as enzymes, antibiotics, antifolates, antimetabolites and some hormones,” said Tony Fenno, chief operating officer. “Co...